Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Lexirin cleared to enter phase I

May 17, 1996

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Tobishi reports outstanding selectivity of it's CCK-A antagonist

May 10, 1996

James Black Foundation describes CCK-B/gastrin receptor antagonist

May 10, 1996

Plasmin/kallikrein inhibitors from Hisamitsu

May 3, 1996

Hepagene preliminary phase III results look positive

May 3, 1996

Somatix hepatitis therapy receives patent coverage

May 3, 1996

Dainippon reports anti-H. pylori compounds

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...